The first cases were isolated: patients brought gonorrhea resistant to conventional treatments from abroad, reports Euronews. The infected individuals were tourists who had visited Southeast Asian countries such as Cambodia, Indonesia, Thailand, and Vietnam. These countries are considered the main sources of resistant strains due to their climate, poor sanitary conditions, and rampant prostitution. However, since 2025, the situation has changed: the new form of gonorrhea has ceased to be exotic. It has been found to spread very quickly within European countries. This is not surprising, as an influx of visitors settles in, begins to make contact with locals, including sexual interactions, and nothing prevents mutated gonococci from triumphantly marching through European states that know no borders. In particular, France, Germany, Sweden, and the United Kingdom have reported a significant increase in cases — and these are the countries with the highest number of migrants. Spain and Italy should also be on the list — this is simply logical. The fact that they are not yet mentioned indicates not an absence of the new threat, but rather a poor detection of sexually transmitted diseases by local healthcare. Until now, gonorrhea has been very successfully treatable. It was treated with antibiotics, changing them as new generations of this group of medications emerged. Currently, ceftriaxone (or ceftriaxone) is used in combination with azithromycin for treatment. However, doctors are increasingly encountering cases where the pathogen shows resistance to both medications. The mutated gonococcus survives in the human body and continues to spread further. And this is, frankly, a serious problem. Due to the simplicity and accessibility of treatment, there is a deeply mistaken belief among the public that gonorrhea is "something like a cold": meaning, it is just as easy to get rid of it. Meanwhile, before the era of antibiotics, this disease caused catastrophic consequences for centuries. Read Balzac or Maupassant: their works often describe blind or mentally impaired children born to mothers or fathers suffering from gonorrhea, unable to rid themselves of the disease and passing it on to new generations. It is worth noting that even today, gonorrhea remains one of the most common bacterial sexually transmitted infections. Moreover, according to ECDC, over the past ten years, the registration rates of gonorrhea cases in the European region have increased by 303%! In 2024, 106,331 cases were confirmed — the highest number since monitoring began in the EU in 2009. On a global scale, approximately 82 million new cases are registered annually among people aged 15 to 49. Who is most often affected? Statistics here also provide a telling breakdown. From 2023 to 2024, the overall rate increased mainly due to a 7.9% rise in cases among men, while it decreased by 8.6% among women. The reason, I think, needs no explanation? The disease is most often transmitted among homosexuals: in 2024, 62% of registered cases were among men who have sex with men, compared to 37% combined among heterosexual men and women. This disease needs to be identified and treated as soon as possible; otherwise, severe complications are inevitable. But now, European medicine faces the question — how to treat it if proven medications cease to work? And there is currently no answer to this question.